Actavis UK Group Limited

From Powerbase
Jump to navigation Jump to search

Actavis UK Group Limited is a company on the UK Companies House register with address or ownership links to Israel. This profile is part of UK companies linked to 'Israel'; see UK companies linked to 'Israel': Methodology for how companies were selected and scored.

Profile

Actavis UK Group Limited
Trade name
Logo Actavis UK Group Limited logo.png
Type Private limited Company
Founded 21 May 2015
Founder(s)
Defunct
Headquarters Ridings Point, Whistler Drive, Castleford, England, WF10 5HX, England
Industry 70100 - Activities of head offices
Services
Parent Teva Pharmaceutical Industries Limited
Subsidiaries
Revenue
Number of employees
Homepage allergan.com
  • Category: P / O (Israeli corporate PSC / parent company; officer(s) with an Israeli correspondence address); connection score 3
  • Company number: 09603816[1]
  • Status: Active
  • Type: Private limited Company
  • Incorporated / registered: 21 May 2015
  • SIC: 70100 - Activities of head offices
  • Registered office: Ridings Point, Whistler Drive, Castleford, England, WF10 5HX, England
  • Previous names: Allergan UK Group Limited (21 May 2015 – 22 Jul 2016)
  • Listing / market cap: Not listed. Parent Teva Pharmaceutical Industries ≈ US$48.61bn.[2]

Israel connection:

  • CH PSC: Teva Pharmaceutical Industries Limited (Petah Tikva, Israel), 75%+. No director appointment has an Israeli correspondence address (CH).

Persons with significant control (CH):[1]

  • Teva Pharmaceutical Industries Limited (active) — address: Basel Street, Petach Tikva, 49131, Israel; legal form Corporate; governing law Israeli Company Regulations; registered at Israel; registration number 520013954; country registered Israel; notified 6 Apr 2016; nature of control: ownership of shares – 75% or more; voting rights – 75% or more; right to appoint or remove directors

Directors (CH; 8 director appointments, 2 current; † = Israel correspondence address, 0 appointments):[1]

Directors (month/year as shown by Companies House; † = Israel correspondence address, an address fact only)
Name Born (month/year) Service †
Stephen Michael Charlesworth February 1967 Apr 2020–present
Dean Michael Cooper September 1972 Jul 2018–present
Richard Gordon Daniell January 1967 Aug 2016–Oct 2016
Kim Innes August 1968 Oct 2016–Apr 2020
Nadine Jakes March 1975 May 2015–Aug 2016
Sara Jayne Vincent May 1966 May 2015–Aug 2016
Robert Williams December 1966 Aug 2016–Jun 2018
Jonathan Thomas Wilson November 1972 May 2015–Aug 2016

Latest accounts (income/expenditure): Full accounts for FY to 31 Dec 2025 (filed 23 Sep 2026; scanned, read by OCR; figures in £'000): no operating result; interest receivable 789; net write-back on investments 14,875 (2024: write-off (62,748)); interest payable (31,328); loss for the year £(15,664)k (2024: £(5,432)k); net assets £183,693k.[3]

Arms trade involvement: None documented. The company's stated business is not in the arms trade.

Supply to the IDF / Israel MOD / Israeli security services: None documented in the sources reviewed.

Activities in the occupied territories: Parent group: Who Profits (information valid to July 2012) lists Teva for exploiting the "Palestinian captive market": easy access, products without Arabic labelling and little generic competition.[4] No OPT activity by the UK company was found.

Links to the Israeli government: None documented in the sources reviewed.

WZO / JNF / Jewish Agency / Keren Hayesod: None found in the sources reviewed.

Controversies (protests, legal cases, export-licence rulings):

See also

Notes

  1. ↑ 1.0 1.1 1.2 Companies House, Actavis UK Group Limited (09603816): company overview Find and update company information (GOV.UK).
  2. ↑ CompaniesMarketCap, Teva Pharmaceutical Industries (TEVA) – market capitalization companiesmarketcap.com, October 2026.
  3. ↑ Companies House, Actavis UK Group Limited (09603816): filing history Find and update company information (GOV.UK).
  4. ↑ 4.0 4.1 Who Profits Research Center, Teva Pharmaceutical Industries Who Profits, information valid to 22 July 2012.